Quantitative evaluation of the impact of relaxing eligibility criteria on the risk–benefit profile of drugs for lung cancer based on real‐world data

Abstract Introduction Restrictive eligibility criteria in cancer drug trials result in low enrollment rates and limited population diversity. Relaxed eligibility criteria (REC) based on solid evidence is becoming necessary for stakeholders worldwide. However, the absence of high‐quality, favorable e...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Huiyao Huang, Shuopeng Jia, Xin Wang, Huilei Miao, Hong Fang, Hanqing He, Dawei Wu, Yu Tang, Ning Li
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Wiley 2024-05-01
Cyfres:	Thoracic Cancer
Pynciau:	cancer clinical trials electronic health record (EHR) real‐world data (RWD) relaxed eligibility criteria (REC)
Mynediad Ar-lein:	https://doi.org/10.1111/1759-7714.15269
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!